99% Savings - Buy Urjas Massage Oil Just @1 Rs
Mekold is an allopathic medicine The correct dosage of Mekold depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Mekold is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Mekold safe for pregnant women?
Mekold may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Mekold again without your doctor's advice.
Is the use of Mekold safe during breastfeeding?
Mekold has been seen to have minimal side effects on breastfeeding women.
What is the effect of Mekold on the Kidneys?
Very few cases of side effects of Mekold on kidney have been reported.
What is the effect of Mekold on the Liver?
Side effects of Mekold rarely affect the liver.
What is the effect of Mekold on the Heart?
Very few cases of side effects of Mekold on the heart have been reported.
Mekold should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Mekold unless your doctor advises you to do so -
Is this Mekold habit forming or addictive?
Mekold does not cause addiction.
Interaction between Food and Mekold
Taking Mekold with food does not harm your health.
Interaction between Alcohol and Mekold
It is difficult to say anything about the effect of Mekold and alcohol. No research has been done on this yet.
Yes, Mekold can be taken with paracetamol. No harmful drug interaction has been reported between them. However, if you feel any unpleasant effects then consult your doctor.
Although, Mekold is classified as a non-drowsy antihistamine, but it can still cause drowsiness in some people. If you are taking this drug and feeling drowsy, then you are recommended not to drive or use heavy machinery. Please consult your doctor if you experience any unwanted side- effects.
Discontinuation of Mekold on your own can cause unwanted side effects and withdrawal symptoms. You are recommended to always consult a doctor before discontinuing this medicine.
No, taking Mekold does not cause weight gain. However, long-term usage of this drug may rarely cause some weight gain. You are recommended to inform your doctor if you are experiencing any weight gain while consuming Mekold.
Absorption of Mekold is not affected by food and hence can be taken with or without food. Preferably it should be taken in the evening. However, you are recommended to take it as per the doctor's instructions.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 166-167
April Hazard Vallerand, Cynthia A. Sanoski. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 316-317
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; ZYRTEC® (cetirizine hydrochloride) Tablets and Syrup For Oral Use
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vazculep (phenylephrine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 135-136
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1020-1022
